Cargando…
Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
Autores principales: | Njonnou, Sylvain Raoul Simeni, Lekpa, Fernando Kemta, Vounsia, Eric Balti, Kenfack, Jaures Arnaud Noumedem, Ouankou, Christian Ngongang, Njinkui, Diomede Noukeu, Enyama, Dominique, Noubom, Michel, Choukem, Simeon Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418166/ https://www.ncbi.nlm.nih.gov/pubmed/34527143 http://dx.doi.org/10.11604/pamj.2021.39.127.29437 |
Ejemplares similares
-
The COVID-19 Prevalence among Children: Hypotheses for Low Infection Rate and Few Severe Forms among This Age Group in Sub-Saharan Africa
por: Simeni Njonnou, Sylvain Raoul, et al.
Publicado: (2021) -
Use of WhatsApp®, for distance teaching during COVID-19 pandemic: Experience and perception from a sub-Saharan African setting
por: Enyama, Dominique, et al.
Publicado: (2021) -
Availability of drugs for severe COVID-19 in sub-Saharan Africa
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2020) -
The challenge of COVID-19 case identification and ascertainment in sub-Saharan Africa: the case of Cameroon
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2020) -
Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong
por: Lekpa, Fernando Kemta, et al.
Publicado: (2021)